Phase I/II study everolimus in combination with paclitaxel-carboplatin in patients with advanced adenocarcinoma of the stomach

被引：0
|
作者：
Loong, H. H. [1 ]
Mo, F. [1 ]
Li, L. [2 ]
Lee, C. [3 ]
Lam, K-C. [2 ]
Koh, J. [1 ]
Chiu, P. [4 ]
Teoh, A. [4 ]
Chan, A. T. C. [1 ]
Ng, E. [4 ]
Yeo, W. [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[3] United Christian Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
402P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer
    Bos, AME
    De Vos, FYFL
    de Vries, EGE
    Beijnen, JH
    Rosing, H
    Mourits, MJE
    van der Zee, AGJ
    Gietema, JA
    Willemse, PHB
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (04) : 539 - 548
  • [42] A phase I/II study of carboplatin and paclitaxel in patients with epithelial ovarian cancer
    Yamamoto, R
    Minobe, S
    Kaneuchi, M
    Sakuragi, N
    Fujimoto, S
    Ishizaki, Y
    Domon, H
    Hareyama, H
    Sato, C
    Fujino, T
    Kawaguchi, I
    Yamaguchi, T
    Fujimoto, T
    Yoshiaki, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (04) : 128 - 134
  • [43] Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer - A multicenter phase II trial
    Potamianou, A
    Androulakis, N
    Papakotoulas, P
    Toufexi, H
    Latoufis, C
    Kouroussis, C
    Christofilakis, C
    Xenidis, N
    Georgoulias, V
    Polyzos, A
    ONCOLOGY, 2005, 69 (04) : 348 - 353
  • [44] Weekly paclitaxel-carboplatin (WPCB) as frontline chemotherapy in metastatic endometrial cancer: A phase II study
    Lanzetta, G.
    Rozzi, A.
    Nardoni, C.
    Corona, M.
    Fanfani, F.
    Scambia, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI82 - XI82
  • [45] Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma
    Clark, JI
    Hofmeister, C
    Choudhury, A
    Matz, G
    Collins, S
    Bastian, R
    Melian, E
    Emami, B
    Petruzzelli, G
    CANCER, 2001, 92 (09) : 2334 - 2340
  • [46] Phase I / II Study of Carboplatin, Nab-Paclitaxel, and Concurrent Radiotherapy for Patients with Locally Advanced NSCLC
    Kawano, Y.
    Sasaki, T.
    Yamaguchi, H.
    Hirano, K.
    Nishio, M.
    Satouchi, M.
    Hosokawa, S.
    Morinaga, R.
    Komiya, K.
    Inoue, K.
    Fujita, Y.
    Toyozawa, R.
    Kimura, T.
    Takahashi, K.
    Nishikawa, K.
    Kishimoto, J.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S635 - S635
  • [47] Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma
    Yoo, Heon Jong
    Lim, Myong Cheol
    Lim, Soyi
    Park, Jeong-Yeol
    Kang, Sokbom
    Park, Sang-Yoon
    Seo, Sang-Soo
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (06) : 1529 - 1535
  • [48] Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma
    Heon Jong Yoo
    Myong Cheol Lim
    Soyi Lim
    Jeong-Yeol Park
    Sokbom Kang
    Sang-Yoon Park
    Sang-Soo Seo
    Archives of Gynecology and Obstetrics, 2012, 286 : 1529 - 1535
  • [49] A feasibility study on maintenance of docetaxel after paclitaxel-carboplatin chemotherapy in patients with advanced ovarian cancer
    Isonishi, Seiji
    Suzuki, Masaaki
    Nagano, Hiroaki
    Takagi, Koichiro
    Shimauchi, Masahito
    Kawabata, Masakiyo
    Ochiai, Kazuhiko
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (02) : 154 - 159
  • [50] Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma
    Yan, Xieqiao
    Sheng, Xinan
    Chi, Zhihong
    Si, Lu
    Cui, Chuanliang
    Kong, Yan
    Tang, Bixia
    Mao, Lili
    Wang, Xuan
    Lian, Bin
    Li, Siming
    Bai, Xue
    Zhou, Li
    Dai, Jie
    Yao, Hong
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (08) : 881 - +
12345